<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d76">
    <sentence id="DDI-DrugBank.d76.s0" text="Potential for Interaction with Monoamine Oxidase Inhibitors">
        <entity charOffset="31-58" id="DDI-DrugBank.d76.s0.e0" text="Monoamine Oxidase Inhibitors" type="group"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s1" text="In patients receiving another serotonin reuptake inhibitor drug in combination with monoamine oxidase inhibitors (MAOI), there have been reports of serious, sometimes fatal, reactions including hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, and mental status changes that include extreme agitation progressing to delirium and coma.">
        <entity charOffset="30-62" id="DDI-DrugBank.d76.s1.e0" text="serotonin reuptake inhibitor drug" type="group"/>
        <entity charOffset="84-111" id="DDI-DrugBank.d76.s1.e1" text="monoamine oxidase inhibitors" type="group"/>
        <entity charOffset="114-117" id="DDI-DrugBank.d76.s1.e2" text="MAOI" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s1.e0" e2="DDI-DrugBank.d76.s1.e1" id="DDI-DrugBank.d76.s1.p0" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s1.e0" e2="DDI-DrugBank.d76.s1.e2" id="DDI-DrugBank.d76.s1.p1" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s1.e1" e2="DDI-DrugBank.d76.s1.e2" id="DDI-DrugBank.d76.s1.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s2" text="These reactions have also been reported in patients who have discontinued that drug and have been started on a MAOI.">
        <entity charOffset="111-114" id="DDI-DrugBank.d76.s2.e0" text="MAOI" type="group"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s3" text="Some cases presented with features resembling neuroleptic malignant syndrome."/>
    <sentence id="DDI-DrugBank.d76.s4" text="Therefore, it is recommended that Fluvoxamine Tablets not be used in combination with MAOIs, or within 14 days of discontinuing treatment with a MAOI.">
        <entity charOffset="34-44" id="DDI-DrugBank.d76.s4.e0" text="Fluvoxamine" type="drug"/>
        <entity charOffset="86-90" id="DDI-DrugBank.d76.s4.e1" text="MAOIs" type="group"/>
        <entity charOffset="145-148" id="DDI-DrugBank.d76.s4.e2" text="MAOI" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s4.e0" e2="DDI-DrugBank.d76.s4.e1" id="DDI-DrugBank.d76.s4.p0" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s4.e0" e2="DDI-DrugBank.d76.s4.e2" id="DDI-DrugBank.d76.s4.p1" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s4.e1" e2="DDI-DrugBank.d76.s4.e2" id="DDI-DrugBank.d76.s4.p2"/>
    <negationtags>Therefore, it is recommended that Fluvoxamine Tablets &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be used in combination with MAOIs, or within 14 days of discontinuing treatment with a MAOI. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d76.s5" text="After stopping Fluvoxamine Tablets, at least 2 weeks should be allowed before starting a MAOI.">
        <entity charOffset="15-25" id="DDI-DrugBank.d76.s5.e0" text="Fluvoxamine" type="drug"/>
        <entity charOffset="89-92" id="DDI-DrugBank.d76.s5.e1" text="MAOI" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s5.e0" e2="DDI-DrugBank.d76.s5.e1" id="DDI-DrugBank.d76.s5.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s6" text="Potential Terfenadine, Astemizole, and Cisapride Interactions">
        <entity charOffset="10-20" id="DDI-DrugBank.d76.s6.e0" text="Terfenadine" type="drug"/>
        <entity charOffset="23-32" id="DDI-DrugBank.d76.s6.e1" text="Astemizole" type="drug"/>
        <entity charOffset="39-47" id="DDI-DrugBank.d76.s6.e2" text="Cisapride" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s6.e0" e2="DDI-DrugBank.d76.s6.e1" id="DDI-DrugBank.d76.s6.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s6.e0" e2="DDI-DrugBank.d76.s6.e2" id="DDI-DrugBank.d76.s6.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s6.e1" e2="DDI-DrugBank.d76.s6.e2" id="DDI-DrugBank.d76.s6.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s7" text="Terfenadine, astemizole and cisapride are all metabolized by the cytochrome P450IIIA4 isozyme, and it has been demonstrated that ketoconazole, a potent inhibitor of IIIA4, blocks the metabolism of these drugs, resulting in increased plasma concentrations of parent drug.">
        <entity charOffset="0-10" id="DDI-DrugBank.d76.s7.e0" text="Terfenadine" type="drug"/>
        <entity charOffset="13-22" id="DDI-DrugBank.d76.s7.e1" text="astemizole" type="drug"/>
        <entity charOffset="28-36" id="DDI-DrugBank.d76.s7.e2" text="cisapride" type="drug"/>
        <entity charOffset="129-140" id="DDI-DrugBank.d76.s7.e3" text="ketoconazole" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s7.e0" e2="DDI-DrugBank.d76.s7.e1" id="DDI-DrugBank.d76.s7.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s7.e0" e2="DDI-DrugBank.d76.s7.e2" id="DDI-DrugBank.d76.s7.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s7.e0" e2="DDI-DrugBank.d76.s7.e3" id="DDI-DrugBank.d76.s7.p2" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s7.e1" e2="DDI-DrugBank.d76.s7.e2" id="DDI-DrugBank.d76.s7.p3"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s7.e1" e2="DDI-DrugBank.d76.s7.e3" id="DDI-DrugBank.d76.s7.p4" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s7.e2" e2="DDI-DrugBank.d76.s7.e3" id="DDI-DrugBank.d76.s7.p5" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s8" text="Increased plasma concentrations of terfenadine, astemizole, and cisapride cause QT prolongation and have been associated with torsades de pointes-type ventricular tachycardia, sometimes fatal.">
        <entity charOffset="35-45" id="DDI-DrugBank.d76.s8.e0" text="terfenadine" type="drug"/>
        <entity charOffset="48-57" id="DDI-DrugBank.d76.s8.e1" text="astemizole" type="drug"/>
        <entity charOffset="64-72" id="DDI-DrugBank.d76.s8.e2" text="cisapride" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s8.e0" e2="DDI-DrugBank.d76.s8.e1" id="DDI-DrugBank.d76.s8.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s8.e0" e2="DDI-DrugBank.d76.s8.e2" id="DDI-DrugBank.d76.s8.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s8.e1" e2="DDI-DrugBank.d76.s8.e2" id="DDI-DrugBank.d76.s8.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s9" text="As noted below, a sub- for fluvoxamine in combination with alprazolam, a drug that is known to be metabolized by the IIIA4 isozyme.">
        <entity charOffset="27-37" id="DDI-DrugBank.d76.s9.e0" text="fluvoxamine" type="drug"/>
        <entity charOffset="59-68" id="DDI-DrugBank.d76.s9.e1" text="alprazolam" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s9.e0" e2="DDI-DrugBank.d76.s9.e1" id="DDI-DrugBank.d76.s9.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s10" text="Although it has not been definitively demonstrated that fluvoxamine is a potent IIIA4 inhibitor, it is likely to be, given the substantial interaction of fluvoxamine with alprazolam.">
        <entity charOffset="56-66" id="DDI-DrugBank.d76.s10.e0" text="fluvoxamine" type="drug"/>
        <entity charOffset="154-164" id="DDI-DrugBank.d76.s10.e1" text="fluvoxamine" type="drug"/>
        <entity charOffset="171-180" id="DDI-DrugBank.d76.s10.e2" text="alprazolam" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s10.e0" e2="DDI-DrugBank.d76.s10.e1" id="DDI-DrugBank.d76.s10.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s10.e0" e2="DDI-DrugBank.d76.s10.e2" id="DDI-DrugBank.d76.s10.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s10.e1" e2="DDI-DrugBank.d76.s10.e2" id="DDI-DrugBank.d76.s10.p2" type="int"/>
    <negationtags>Although it has &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been definitively demonstrated that fluvoxamine is a potent IIIA4 inhibitor, it is likely to be, given the substantial interaction of fluvoxamine with alprazolam. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d76.s11" text="Consequently, it is recommended that fluvoxamine not be used in combination with either terbinafine, astemizole, or cisapride.">
        <entity charOffset="37-47" id="DDI-DrugBank.d76.s11.e0" text="fluvoxamine" type="drug"/>
        <entity charOffset="88-98" id="DDI-DrugBank.d76.s11.e1" text="terbinafine" type="drug"/>
        <entity charOffset="101-110" id="DDI-DrugBank.d76.s11.e2" text="astemizole" type="drug"/>
        <entity charOffset="116-124" id="DDI-DrugBank.d76.s11.e3" text="cisapride" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s11.e0" e2="DDI-DrugBank.d76.s11.e1" id="DDI-DrugBank.d76.s11.p0" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s11.e0" e2="DDI-DrugBank.d76.s11.e2" id="DDI-DrugBank.d76.s11.p1" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s11.e0" e2="DDI-DrugBank.d76.s11.e3" id="DDI-DrugBank.d76.s11.p2" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s11.e1" e2="DDI-DrugBank.d76.s11.e2" id="DDI-DrugBank.d76.s11.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s11.e1" e2="DDI-DrugBank.d76.s11.e3" id="DDI-DrugBank.d76.s11.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s11.e2" e2="DDI-DrugBank.d76.s11.e3" id="DDI-DrugBank.d76.s11.p5"/>
    <negationtags>Consequently, it is recommended that fluvoxamine &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be used in combination with either terbinafine, astemizole, or cisapride. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d76.s12" text="Other Potentially Important Drug Interactions: Benzodiazepines: Benzodiazepines metabolized by hepatic oxidation (e.g., alprazolam, midazolam, triazolam elc.) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine.">
        <entity charOffset="47-61" id="DDI-DrugBank.d76.s12.e0" text="Benzodiazepines" type="group"/>
        <entity charOffset="64-78" id="DDI-DrugBank.d76.s12.e1" text="Benzodiazepines" type="group"/>
        <entity charOffset="120-129" id="DDI-DrugBank.d76.s12.e2" text="alprazolam" type="drug"/>
        <entity charOffset="132-140" id="DDI-DrugBank.d76.s12.e3" text="midazolam" type="drug"/>
        <entity charOffset="143-151" id="DDI-DrugBank.d76.s12.e4" text="triazolam" type="drug"/>
        <entity charOffset="251-261" id="DDI-DrugBank.d76.s12.e5" text="fluvoxamine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s12.e0" e2="DDI-DrugBank.d76.s12.e1" id="DDI-DrugBank.d76.s12.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s12.e0" e2="DDI-DrugBank.d76.s12.e2" id="DDI-DrugBank.d76.s12.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s12.e0" e2="DDI-DrugBank.d76.s12.e3" id="DDI-DrugBank.d76.s12.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s12.e0" e2="DDI-DrugBank.d76.s12.e4" id="DDI-DrugBank.d76.s12.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s12.e0" e2="DDI-DrugBank.d76.s12.e5" id="DDI-DrugBank.d76.s12.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s12.e1" e2="DDI-DrugBank.d76.s12.e2" id="DDI-DrugBank.d76.s12.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s12.e1" e2="DDI-DrugBank.d76.s12.e3" id="DDI-DrugBank.d76.s12.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s12.e1" e2="DDI-DrugBank.d76.s12.e4" id="DDI-DrugBank.d76.s12.p7"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s12.e1" e2="DDI-DrugBank.d76.s12.e5" id="DDI-DrugBank.d76.s12.p8" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s12.e2" e2="DDI-DrugBank.d76.s12.e3" id="DDI-DrugBank.d76.s12.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s12.e2" e2="DDI-DrugBank.d76.s12.e4" id="DDI-DrugBank.d76.s12.p10"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s12.e2" e2="DDI-DrugBank.d76.s12.e5" id="DDI-DrugBank.d76.s12.p11" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s12.e3" e2="DDI-DrugBank.d76.s12.e4" id="DDI-DrugBank.d76.s12.p12"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s12.e3" e2="DDI-DrugBank.d76.s12.e5" id="DDI-DrugBank.d76.s12.p13" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s12.e4" e2="DDI-DrugBank.d76.s12.e5" id="DDI-DrugBank.d76.s12.p14" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s13" text="The clearance of benzodiazepines metabolized by glucuronidation (e. g., lorazepam, oxazepam, temazepam) is unlikely to be affected by fluvoxamine.">
        <entity charOffset="17-31" id="DDI-DrugBank.d76.s13.e0" text="benzodiazepines" type="group"/>
        <entity charOffset="72-80" id="DDI-DrugBank.d76.s13.e1" text="lorazepam" type="drug"/>
        <entity charOffset="83-90" id="DDI-DrugBank.d76.s13.e2" text="oxazepam" type="drug"/>
        <entity charOffset="93-101" id="DDI-DrugBank.d76.s13.e3" text="temazepam" type="drug"/>
        <entity charOffset="134-144" id="DDI-DrugBank.d76.s13.e4" text="fluvoxamine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s13.e0" e2="DDI-DrugBank.d76.s13.e1" id="DDI-DrugBank.d76.s13.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s13.e0" e2="DDI-DrugBank.d76.s13.e2" id="DDI-DrugBank.d76.s13.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s13.e0" e2="DDI-DrugBank.d76.s13.e3" id="DDI-DrugBank.d76.s13.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s13.e0" e2="DDI-DrugBank.d76.s13.e4" id="DDI-DrugBank.d76.s13.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s13.e1" e2="DDI-DrugBank.d76.s13.e2" id="DDI-DrugBank.d76.s13.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s13.e1" e2="DDI-DrugBank.d76.s13.e3" id="DDI-DrugBank.d76.s13.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s13.e1" e2="DDI-DrugBank.d76.s13.e4" id="DDI-DrugBank.d76.s13.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s13.e2" e2="DDI-DrugBank.d76.s13.e3" id="DDI-DrugBank.d76.s13.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s13.e2" e2="DDI-DrugBank.d76.s13.e4" id="DDI-DrugBank.d76.s13.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s13.e3" e2="DDI-DrugBank.d76.s13.e4" id="DDI-DrugBank.d76.s13.p9"/>
    <negationtags>&lt;scope&gt; The clearance of benzodiazepines metabolized by glucuronidation (e. g., lorazepam, oxazepam, temazepam) is &lt;cue&gt; unlikely &lt;/cue&gt; &lt;/scope&gt; to be affected by fluvoxamine.</negationtags></sentence>
    <sentence id="DDI-DrugBank.d76.s14" text="Alprazolam: When fluvoxamine maleate (100 mg qd) and alprazolam (1 mg q.d. were co-administered to steady state, plasma concentration and other pharmacokinetics parameters (AUC, Cmax, T1/2,) of alprazolam were approximately twice those observed when alprazolam was administered alone;">
        <entity charOffset="0-9" id="DDI-DrugBank.d76.s14.e0" text="Alprazolam" type="drug"/>
        <entity charOffset="17-35" id="DDI-DrugBank.d76.s14.e1" text="fluvoxamine maleate" type="drug"/>
        <entity charOffset="53-62" id="DDI-DrugBank.d76.s14.e2" text="alprazolam" type="drug"/>
        <entity charOffset="194-203" id="DDI-DrugBank.d76.s14.e3" text="alprazolam" type="drug"/>
        <entity charOffset="250-259" id="DDI-DrugBank.d76.s14.e4" text="alprazolam" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s14.e0" e2="DDI-DrugBank.d76.s14.e1" id="DDI-DrugBank.d76.s14.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s14.e0" e2="DDI-DrugBank.d76.s14.e2" id="DDI-DrugBank.d76.s14.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s14.e0" e2="DDI-DrugBank.d76.s14.e3" id="DDI-DrugBank.d76.s14.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s14.e0" e2="DDI-DrugBank.d76.s14.e4" id="DDI-DrugBank.d76.s14.p3"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s14.e1" e2="DDI-DrugBank.d76.s14.e2" id="DDI-DrugBank.d76.s14.p4" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s14.e1" e2="DDI-DrugBank.d76.s14.e3" id="DDI-DrugBank.d76.s14.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s14.e1" e2="DDI-DrugBank.d76.s14.e4" id="DDI-DrugBank.d76.s14.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s14.e2" e2="DDI-DrugBank.d76.s14.e3" id="DDI-DrugBank.d76.s14.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s14.e2" e2="DDI-DrugBank.d76.s14.e4" id="DDI-DrugBank.d76.s14.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s14.e3" e2="DDI-DrugBank.d76.s14.e4" id="DDI-DrugBank.d76.s14.p9"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s15" text="oral clearance was reduced by about 50%."/>
    <sentence id="DDI-DrugBank.d76.s16" text="The elevated plasma alprazolam concentrations resulted in decreased psychomotor performance and memory.">
        <entity charOffset="20-29" id="DDI-DrugBank.d76.s16.e0" text="alprazolam" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s17" text="This interaction, which has not been investigated using higher doses of fluvoxamine, may be more pronounced if a 300 mg daily dose is co-administered, particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg. If alprazolam is co-administered with Fluvoxamine Tablets, the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended.">
        <entity charOffset="72-82" id="DDI-DrugBank.d76.s17.e0" text="fluvoxamine" type="drug"/>
        <entity charOffset="170-180" id="DDI-DrugBank.d76.s17.e1" text="fluvoxamine" type="drug"/>
        <entity charOffset="256-265" id="DDI-DrugBank.d76.s17.e2" text="alprazolam" type="drug"/>
        <entity charOffset="291-301" id="DDI-DrugBank.d76.s17.e3" text="Fluvoxamine" type="drug"/>
        <entity charOffset="324-333" id="DDI-DrugBank.d76.s17.e4" text="alprazolam" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s17.e0" e2="DDI-DrugBank.d76.s17.e1" id="DDI-DrugBank.d76.s17.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s17.e0" e2="DDI-DrugBank.d76.s17.e2" id="DDI-DrugBank.d76.s17.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s17.e0" e2="DDI-DrugBank.d76.s17.e3" id="DDI-DrugBank.d76.s17.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s17.e0" e2="DDI-DrugBank.d76.s17.e4" id="DDI-DrugBank.d76.s17.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s17.e1" e2="DDI-DrugBank.d76.s17.e2" id="DDI-DrugBank.d76.s17.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s17.e1" e2="DDI-DrugBank.d76.s17.e3" id="DDI-DrugBank.d76.s17.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s17.e1" e2="DDI-DrugBank.d76.s17.e4" id="DDI-DrugBank.d76.s17.p6"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s17.e2" e2="DDI-DrugBank.d76.s17.e3" id="DDI-DrugBank.d76.s17.p7" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s17.e2" e2="DDI-DrugBank.d76.s17.e4" id="DDI-DrugBank.d76.s17.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s17.e3" e2="DDI-DrugBank.d76.s17.e4" id="DDI-DrugBank.d76.s17.p9"/>
    <negationtags>This interaction, which has &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been investigated using higher doses of fluvoxamine, may be more pronounced if a 300 mg daily dose is co-administered, particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg. If alprazolam is co-administered with Fluvoxamine Tablets, the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d76.s18" text="No dosage adjustment is required for Fluvoxamine Tablets.">
        <entity charOffset="37-47" id="DDI-DrugBank.d76.s18.e0" text="Fluvoxamine" type="drug"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; dosage adjustment is required for Fluvoxamine Tablets. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d76.s19" text="Diazepam: The co-administration of Fluvoxamine Tablets and diazepam is generally not advisable.">
        <entity charOffset="0-7" id="DDI-DrugBank.d76.s19.e0" text="Diazepam" type="drug"/>
        <entity charOffset="35-45" id="DDI-DrugBank.d76.s19.e1" text="Fluvoxamine" type="drug"/>
        <entity charOffset="59-66" id="DDI-DrugBank.d76.s19.e2" text="diazepam" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s19.e0" e2="DDI-DrugBank.d76.s19.e1" id="DDI-DrugBank.d76.s19.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s19.e0" e2="DDI-DrugBank.d76.s19.e2" id="DDI-DrugBank.d76.s19.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s19.e1" e2="DDI-DrugBank.d76.s19.e2" id="DDI-DrugBank.d76.s19.p2" type="advise"/>
    <negationtags>Diazepam: The co-administration of Fluvoxamine Tablets and diazepam is generally &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; advisable. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d76.s20" text="Because fluvoxamine reduces the clearance of both diazepam and its active metabolite, N-desmethyldiazepam, there is a strong likelihood of substantial accumulation of both species during chronic co-administration.">
        <entity charOffset="8-18" id="DDI-DrugBank.d76.s20.e0" text="fluvoxamine" type="drug"/>
        <entity charOffset="50-57" id="DDI-DrugBank.d76.s20.e1" text="diazepam" type="drug"/>
        <entity charOffset="86-104" id="DDI-DrugBank.d76.s20.e2" text="N-desmethyldiazepam" type="drug_n"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s20.e0" e2="DDI-DrugBank.d76.s20.e1" id="DDI-DrugBank.d76.s20.p0" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s20.e0" e2="DDI-DrugBank.d76.s20.e2" id="DDI-DrugBank.d76.s20.p1" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s20.e1" e2="DDI-DrugBank.d76.s20.e2" id="DDI-DrugBank.d76.s20.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s21" text="Evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam.">
        <entity charOffset="75-85" id="DDI-DrugBank.d76.s21.e0" text="fluvoxamine" type="drug"/>
        <entity charOffset="91-98" id="DDI-DrugBank.d76.s21.e1" text="diazepam" type="drug"/>
        <entity charOffset="173-183" id="DDI-DrugBank.d76.s21.e2" text="fluvoxamine" type="drug"/>
        <entity charOffset="234-241" id="DDI-DrugBank.d76.s21.e3" text="diazepam" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s21.e0" e2="DDI-DrugBank.d76.s21.e1" id="DDI-DrugBank.d76.s21.p0" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s21.e0" e2="DDI-DrugBank.d76.s21.e2" id="DDI-DrugBank.d76.s21.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s21.e0" e2="DDI-DrugBank.d76.s21.e3" id="DDI-DrugBank.d76.s21.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s21.e1" e2="DDI-DrugBank.d76.s21.e2" id="DDI-DrugBank.d76.s21.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s21.e1" e2="DDI-DrugBank.d76.s21.e3" id="DDI-DrugBank.d76.s21.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s21.e2" e2="DDI-DrugBank.d76.s21.e3" id="DDI-DrugBank.d76.s21.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s22" text="In these subjects (R= B), the clearance of diazepam was reduced by 65% and that of N-desmethyldiazepam to a level that was too low to measure over the course of the 2 week long study.">
        <entity charOffset="43-50" id="DDI-DrugBank.d76.s22.e0" text="diazepam" type="drug"/>
        <entity charOffset="83-101" id="DDI-DrugBank.d76.s22.e1" text="N-desmethyldiazepam" type="drug_n"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s22.e0" e2="DDI-DrugBank.d76.s22.e1" id="DDI-DrugBank.d76.s22.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s23" text="It is likely that experience significantly underestimates the degree of accumulation that might occur with repealed diazepam administration.">
        <entity charOffset="116-123" id="DDI-DrugBank.d76.s23.e0" text="diazepam" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s24" text="Moreover, as noted with alprazolam, the effect of fluvoxamine may even be more pronounced when it is administered at higher doses.">
        <entity charOffset="24-33" id="DDI-DrugBank.d76.s24.e0" text="alprazolam" type="drug"/>
        <entity charOffset="50-60" id="DDI-DrugBank.d76.s24.e1" text="fluvoxamine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s24.e0" e2="DDI-DrugBank.d76.s24.e1" id="DDI-DrugBank.d76.s24.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s25" text="Accordingly, diazepam and fluvoxamine should not ordinarily be co-administered.">
        <entity charOffset="13-20" id="DDI-DrugBank.d76.s25.e0" text="diazepam" type="drug"/>
        <entity charOffset="26-36" id="DDI-DrugBank.d76.s25.e1" text="fluvoxamine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s25.e0" e2="DDI-DrugBank.d76.s25.e1" id="DDI-DrugBank.d76.s25.p0" type="advise"/>
    <negationtags>Accordingly, diazepam and fluvoxamine should &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; ordinarily be co-administered. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d76.s26" text="Theophylline: The effect of steady-state fluvoxamine l50 mg bid on the pharmacokinetics of a single dose of Theophylline (375 mg) as 442 mg aminophylline was evaluated in 12 healthy non-smoking, male volunteers.">
        <entity charOffset="0-11" id="DDI-DrugBank.d76.s26.e0" text="Theophylline" type="drug"/>
        <entity charOffset="41-51" id="DDI-DrugBank.d76.s26.e1" text="fluvoxamine" type="drug"/>
        <entity charOffset="108-119" id="DDI-DrugBank.d76.s26.e2" text="Theophylline" type="drug"/>
        <entity charOffset="140-152" id="DDI-DrugBank.d76.s26.e3" text="aminophylline" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s26.e0" e2="DDI-DrugBank.d76.s26.e1" id="DDI-DrugBank.d76.s26.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s26.e0" e2="DDI-DrugBank.d76.s26.e2" id="DDI-DrugBank.d76.s26.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s26.e0" e2="DDI-DrugBank.d76.s26.e3" id="DDI-DrugBank.d76.s26.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s26.e1" e2="DDI-DrugBank.d76.s26.e2" id="DDI-DrugBank.d76.s26.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s26.e1" e2="DDI-DrugBank.d76.s26.e3" id="DDI-DrugBank.d76.s26.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s26.e2" e2="DDI-DrugBank.d76.s26.e3" id="DDI-DrugBank.d76.s26.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s27" text="The clearance of theophylline was decreased approximately 3-fold.">
        <entity charOffset="17-28" id="DDI-DrugBank.d76.s27.e0" text="theophylline" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s28" text="Therefore, if theophylline is co-administered with fluvoxamine maleate, its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of theophylline should to monitored.">
        <entity charOffset="14-25" id="DDI-DrugBank.d76.s28.e0" text="theophylline" type="drug"/>
        <entity charOffset="51-69" id="DDI-DrugBank.d76.s28.e1" text="fluvoxamine maleate" type="drug"/>
        <entity charOffset="177-188" id="DDI-DrugBank.d76.s28.e2" text="theophylline" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s28.e0" e2="DDI-DrugBank.d76.s28.e1" id="DDI-DrugBank.d76.s28.p0" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s28.e0" e2="DDI-DrugBank.d76.s28.e2" id="DDI-DrugBank.d76.s28.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s28.e1" e2="DDI-DrugBank.d76.s28.e2" id="DDI-DrugBank.d76.s28.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s29" text="No dosage adjustment is required for Fluvoxamine Tablets.">
        <entity charOffset="37-47" id="DDI-DrugBank.d76.s29.e0" text="Fluvoxamine" type="drug"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; dosage adjustment is required for Fluvoxamine Tablets. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d76.s30" text="Warfarin: When fluvoxamine maleate (50 mg tid) was administered concomitantly with warfarin for two weeks, warfarin plasma concentrations increased by 98% and prothrombin times were prolonged.">
        <entity charOffset="0-7" id="DDI-DrugBank.d76.s30.e0" text="Warfarin" type="drug"/>
        <entity charOffset="15-33" id="DDI-DrugBank.d76.s30.e1" text="fluvoxamine maleate" type="drug"/>
        <entity charOffset="83-90" id="DDI-DrugBank.d76.s30.e2" text="warfarin" type="drug"/>
        <entity charOffset="107-114" id="DDI-DrugBank.d76.s30.e3" text="warfarin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s30.e0" e2="DDI-DrugBank.d76.s30.e1" id="DDI-DrugBank.d76.s30.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s30.e0" e2="DDI-DrugBank.d76.s30.e2" id="DDI-DrugBank.d76.s30.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s30.e0" e2="DDI-DrugBank.d76.s30.e3" id="DDI-DrugBank.d76.s30.p2"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s30.e1" e2="DDI-DrugBank.d76.s30.e2" id="DDI-DrugBank.d76.s30.p3" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s30.e1" e2="DDI-DrugBank.d76.s30.e3" id="DDI-DrugBank.d76.s30.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s30.e2" e2="DDI-DrugBank.d76.s30.e3" id="DDI-DrugBank.d76.s30.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s31" text="Thus patients receiving oral anticoagulants and Fluvoxamine Tablets should have their prothrombin time monitored and their anticoagulant dose adjusted accordingly.">
        <entity charOffset="29-42" id="DDI-DrugBank.d76.s31.e0" text="anticoagulants" type="group"/>
        <entity charOffset="48-58" id="DDI-DrugBank.d76.s31.e1" text="Fluvoxamine" type="drug"/>
        <entity charOffset="123-135" id="DDI-DrugBank.d76.s31.e2" text="anticoagulant" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d76.s31.e0" e2="DDI-DrugBank.d76.s31.e1" id="DDI-DrugBank.d76.s31.p0" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s31.e0" e2="DDI-DrugBank.d76.s31.e2" id="DDI-DrugBank.d76.s31.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d76.s31.e1" e2="DDI-DrugBank.d76.s31.e2" id="DDI-DrugBank.d76.s31.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d76.s32" text="No dosage adjustment is required for Fluvoxamine Tablets.">
        <entity charOffset="37-47" id="DDI-DrugBank.d76.s32.e0" text="Fluvoxamine" type="drug"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; dosage adjustment is required for Fluvoxamine Tablets. &lt;/scope&gt;</negationtags></sentence>
</document>